CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $1.94M, a 27.14% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$3.08M, a 334.27% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $2.17M, a 30.61% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $971.65K, a 168.83% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $5.98M, a 208.27% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was $1.94M, a 46.35% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $1.33M, a 22.81% decline from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was $1.72M, a 328.77% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 102 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 105 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.14M 10-Q · filed 2026-08-14 | $1.03M derived: sum of 3 quarters · filed 2026-08-14 | $2.00M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | -$3.08M 10-Q · filed 2026-05-13 | -$913.10K derived: sum of 2 quarters · filed 2026-05-13 | $58.54K derived: sum of 3 quarters · filed 2026-05-13 | $1.59M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.14M derived: sum of 2 quarters · filed 2026-03-17 | $4.67M derived: sum of 3 quarters · filed 2026-08-14 | $5.98M 10-K · filed 2026-03-17 | ||||||
| 2025-09-30 | $971.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.50M derived: sum of 2 quarters · filed 2026-08-14 | $3.82M 10-Q · filed 2025-11-10 | $5.48M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.84M 10-Q · filed 2026-08-14 | $4.50M derived: sum of 3 quarters · filed 2026-08-14 | $4.87M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | $1.32M 10-Q · filed 2026-05-13 | $2.98M derived: sum of 2 quarters · filed 2026-05-13 | $3.34M derived: sum of 3 quarters · filed 2026-05-13 | $3.26M derived: sum of 4 quarters · filed 2026-05-13 | ||||||
| 2024-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $2.02M derived: sum of 2 quarters · filed 2026-03-17 | $1.94M derived: sum of 3 quarters · filed 2026-03-17 | $1.94M 10-K · filed 2026-03-17 | ||||||
| 2024-09-30 | $361.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $282.71K derived: sum of 2 quarters · filed 2025-11-10 | $281.12K 10-Q · filed 2025-11-10 | -$260.59K derived: sum of 4 quarters · filed 2025-11-10 | ||||||
| 2024-06-30 | -$78.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$80.31K 10-Q · filed 2025-08-11 | -$622.02K derived: sum of 3 quarters · filed 2025-08-11 | $1.04M derived: sum of 4 quarters · filed 2025-08-11 | ||||||
| 2024-03-31 | -$1.58K 10-Q · filed 2025-05-14 | -$543.29K derived: sum of 2 quarters · filed 2025-05-14 | $1.11M derived: sum of 3 quarters · filed 2025-05-14 | $822.92K derived: sum of 4 quarters · filed 2025-05-14 | ||||||
| 2023-12-31 | -$541.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.12M derived: sum of 2 quarters · filed 2025-03-26 | $824.51K derived: sum of 3 quarters · filed 2025-03-26 | $1.33M 10-K · filed 2025-03-26 | $1.39M 10-K · filed 2024-03-11 | |||||
| 2023-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.37M derived: sum of 2 quarters · filed 2024-11-14 | $1.87M 10-Q · filed 2024-11-14 | $1.94M 10-Q · filed 2023-11-14 | $2.85M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | -$291.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $209.89K 10-Q · filed 2024-08-08 | $280.50K 10-Q · filed 2023-08-08 | $1.19M derived: sum of 3 quarters · filed 2024-08-08 | $1.92M derived: sum of 4 quarters · filed 2024-08-08 | |||||
| 2023-03-31 | $501.81K 10-Q · filed 2024-05-14 | $572.33K 10-Q · filed 2023-05-12 | $1.48M derived: sum of 2 quarters · filed 2024-05-14 | $2.21M derived: sum of 3 quarters · filed 2024-05-14 | $1.81M derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | $982.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.71M derived: sum of 2 quarters · filed 2024-03-11 | $1.31M derived: sum of 3 quarters · filed 2024-03-11 | $1.72M 10-K · filed 2024-03-11 | ||||||
| 2022-09-30 | $724.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $328.78K derived: sum of 2 quarters · filed 2023-11-14 | $735.99K 10-Q · filed 2023-11-14 | $1.36M derived: sum of 4 quarters · filed 2023-11-14 | ||||||
| 2022-06-30 | -$395.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $11.46K 10-Q · filed 2023-08-08 | $636.62K derived: sum of 3 quarters · filed 2023-08-08 | $329.82K derived: sum of 4 quarters · filed 2023-08-08 | ||||||
| 2022-03-31 | $407.20K 10-Q · filed 2023-05-12 | $1.03M derived: sum of 2 quarters · filed 2023-05-12 | $725.56K derived: sum of 3 quarters · filed 2023-05-12 | $375.71K derived: sum of 4 quarters · filed 2023-05-12 | ||||||
| 2021-12-31 | $625.16K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $318.36K derived: sum of 2 quarters · filed 2023-03-17 | -$31.49K derived: sum of 3 quarters · filed 2023-03-17 | $400.75K 10-K · filed 2023-03-17 | ||||||
| 2021-09-30 | -$306.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$656.65K derived: sum of 2 quarters · filed 2022-11-10 | -$224.41K 10-Q · filed 2022-11-10 | $263.70K 10-Q · filed 2021-11-12 | $428.81K derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | -$349.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $82.39K 10-Q · filed 2022-08-12 | $449.07K 10-Q · filed 2021-08-13 | $735.61K derived: sum of 3 quarters · filed 2022-08-12 | $1.04M derived: sum of 4 quarters · filed 2022-08-12 | |||||
| 2021-03-31 | $432.24K 10-Q · filed 2022-05-11 | $744.60K 10-Q · filed 2021-05-14 | $1.09M derived: sum of 2 quarters · filed 2022-05-11 | $1.39M derived: sum of 3 quarters · filed 2022-05-11 | $1.85M derived: sum of 4 quarters · filed 2022-05-11 | |||||
| 2020-12-31 | $653.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $960.36K derived: sum of 2 quarters · filed 2022-03-11 | $1.41M derived: sum of 3 quarters · filed 2022-03-11 | $1.84M 10-K · filed 2022-03-11 | $1.83M 10-K · filed 2021-03-15 | |||||
| 2020-09-30 | $307.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $759.82K derived: sum of 2 quarters · filed 2021-11-12 | $1.19M 10-Q · filed 2021-11-12 | $1.12M derived: sum of 4 quarters · filed 2021-11-12 | ||||||
| 2020-06-30 | $452.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $879.59K 10-Q · filed 2021-08-13 | $816.86K derived: sum of 3 quarters · filed 2021-08-13 | $210.78K derived: sum of 4 quarters · filed 2021-08-13 | ||||||
| 2020-03-31 | $426.90K 10-Q · filed 2021-05-14 | $420.59K 10-Q · filed 2020-05-15 | $364.18K derived: sum of 2 quarters · filed 2021-05-14 | -$241.91K derived: sum of 3 quarters · filed 2021-05-14 | -$244.35K derived: sum of 4 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | -$62.73K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$668.81K derived: sum of 2 quarters · filed 2021-03-15 | -$671.25K derived: sum of 3 quarters · filed 2021-03-15 | -$357.23K 10-K · filed 2021-03-15 | -$273.18K 10-K · filed 2020-03-27 | |||||
| 2019-09-30 | -$606.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$608.52K derived: sum of 2 quarters · filed 2020-11-13 | -$294.50K 10-Q · filed 2020-11-13 | -$201.25K 10-Q · filed 2019-11-08 | -$889.43K derived: sum of 4 quarters · filed 2020-11-13 | |||||
| 2019-06-30 | -$2.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $311.58K 10-Q · filed 2020-08-10 | $371.74K 10-Q · filed 2019-08-08 | -$283.35K derived: sum of 3 quarters · filed 2020-08-10 | $254.10K derived: sum of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | $314.03K 10-Q · filed 2020-05-15 | -$280.91K derived: sum of 2 quarters · filed 2020-05-15 | $256.54K derived: sum of 3 quarters · filed 2020-05-15 | $54.54K derived: sum of 4 quarters · filed 2020-05-15 | ||||||
| 2018-12-31 | -$594.93K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$57.48K derived: sum of 2 quarters · filed 2020-03-27 | -$259.49K derived: sum of 3 quarters · filed 2020-03-27 | -$347.40K 10-K · filed 2020-03-27 | ||||||
| 2018-09-30 | $537.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $335.45K derived: sum of 2 quarters · filed 2019-11-08 | $247.54K 10-Q · filed 2019-11-08 | $479.46K derived: sum of 4 quarters · filed 2019-11-08 | ||||||
| 2018-06-30 | -$202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$289.91K 10-Q · filed 2019-08-08 | -$57.99K derived: sum of 3 quarters · filed 2019-08-08 | -$970.94K derived: sum of 4 quarters · filed 2019-08-08 | ||||||
| 2018-03-31 | -$87.91K 10-Q · filed 2019-05-14 | $144.01K derived: sum of 2 quarters · filed 2019-05-14 | -$768.94K derived: sum of 3 quarters · filed 2019-05-14 | -$1.10M derived: sum of 4 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $231.93K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$681.03K derived: sum of 2 quarters · filed 2019-03-29 | -$1.01M derived: sum of 3 quarters · filed 2019-03-29 | -$1.54M 10-K · filed 2019-03-29 | ||||||
| 2017-09-30 | -$912.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.24M derived: sum of 2 quarters · filed 2018-11-14 | -$1.77M 10-Q · filed 2018-11-14 | -$2.66M derived: sum of 4 quarters · filed 2018-11-14 | ||||||
| 2017-06-30 | -$328.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$861.04K 10-Q · filed 2018-08-13 | -$1.74M derived: sum of 3 quarters · filed 2018-08-13 | -$745.86K derived: sum of 4 quarters · filed 2018-08-13 | ||||||
| 2017-03-31 | -$532.98K 10-Q · filed 2018-05-14 | -$1.41M derived: sum of 2 quarters · filed 2018-05-14 | -$417.80K derived: sum of 3 quarters · filed 2018-05-14 | -$718.24K derived: sum of 4 quarters · filed 2018-05-14 | ||||||
| 2016-12-31 | -$881.52K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $115.18K derived: sum of 2 quarters · filed 2018-03-22 | -$185.26K derived: sum of 3 quarters · filed 2018-03-22 | $508.28K 10-K · filed 2018-03-22 | ||||||
| 2016-09-30 | $996.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $696.26K derived: sum of 2 quarters · filed 2017-11-14 | $1.39M 10-Q · filed 2017-11-14 | $1.61M derived: sum of 4 quarters · filed 2017-11-14 | ||||||
| 2016-06-30 | -$300.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $393.10K 10-Q · filed 2017-08-14 | $614.92K derived: sum of 3 quarters · filed 2017-08-14 | $244.75K derived: sum of 4 quarters · filed 2017-08-14 | ||||||
| 2016-03-31 | $693.54K 10-Q · filed 2017-05-15 | $915.37K derived: sum of 2 quarters · filed 2017-05-15 | $545.20K derived: sum of 3 quarters · filed 2017-05-15 | $478.11K derived: sum of 4 quarters · filed 2017-05-15 | ||||||
| 2015-12-31 | $221.82K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$148.35K derived: sum of 2 quarters · filed 2017-03-16 | -$215.44K derived: sum of 3 quarters · filed 2017-03-16 | $831.25K 10-K · filed 2017-03-16 | ||||||
| 2015-09-30 | -$370.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$437.26K derived: sum of 2 quarters · filed 2016-11-14 | $609.42K 10-Q · filed 2016-11-14 | $583.96K derived: sum of 4 quarters · filed 2016-11-14 | ||||||
| 2015-06-30 | -$67.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $979.59K 10-Q · filed 2016-08-15 | $954.13K derived: sum of 3 quarters · filed 2016-08-15 | $853.35K derived: sum of 4 quarters · filed 2016-08-15 | ||||||
| 2015-03-31 | $1.05M 10-Q · filed 2016-05-13 | $1.02M derived: sum of 2 quarters · filed 2016-05-13 | $920.44K derived: sum of 3 quarters · filed 2016-05-13 | $1.09M derived: sum of 4 quarters · filed 2016-05-13 | ||||||
| 2014-12-31 | -$25.46K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$126.25K derived: sum of 2 quarters · filed 2016-03-30 | $48.28K derived: sum of 3 quarters · filed 2016-03-30 | $70.33K 10-K · filed 2016-03-30 | ||||||
| 2014-09-30 | -$100.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $73.74K derived: sum of 2 quarters · filed 2015-11-13 | $95.79K 10-Q · filed 2015-11-13 | $106.56K 10-Q · filed 2014-11-14 | $714.23K derived: sum of 4 quarters · filed 2015-11-13 | |||||
| 2014-06-30 | $174.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $196.57K 10-Q · filed 2015-08-14 | $176.85K 10-Q · filed 2014-08-14 | $815.02K derived: sum of 3 quarters · filed 2015-08-14 | $629.64K derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $22.05K 10-Q · filed 2015-05-13 | $12.09K 10-Q · filed 2014-05-15 | $640.49K derived: sum of 2 quarters · filed 2015-05-13 | $455.11K derived: sum of 3 quarters · filed 2015-05-13 | $929.21K derived: sum of 4 quarters · filed 2015-05-13 | $1.25M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $618.44K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $433.06K derived: sum of 2 quarters · filed 2015-03-16 | $907.16K derived: sum of 3 quarters · filed 2015-03-16 | $1.07M 10-K · filed 2015-03-16 | $974.71K 10-K · filed 2014-03-31 | $1.24M 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | -$185.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $288.72K derived: sum of 2 quarters · filed 2014-11-14 | $453.78K 10-Q · filed 2014-11-14 | |||||||
| 2013-06-30 | $474.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $639.16K 10-Q · filed 2014-08-14 | ||||||||
| 2013-03-31 | $165.06K 10-Q · filed 2014-05-15 | |||||||||
| 2012-12-31 | $77.15K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |